Enfermedad grasa del hígado no alcohólica en pacientes con diabetes mellitus 2
Contenido principal del artículo
Resumen
La enfermedad grasa del hígado no alcohólica incluye tanto la esteatosis como la esteatohepatitis no alcohólica, recientemente se ha incrementado su trascendencia en reconocerla como una condición que potencialmente proporciona daño hepático crónico.
Detalles del artículo
Sección
Cómo citar
Referencias
Brunt EM, et al. Nonalcoholic esteatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterology
; 94: 2467-74.
Santiago TM. Diagnóstico nutricional en el paciente con cirrosis hepática. Hospital Central Militar México D.F. Julio 2003.
Matteoni CA, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-19.
Powell EE, et al. The natural history of nonalcoholic steatohepatitis. Hepatology 1990; 11: 74-80.
Angulo P, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30:1356-62.
Poonwala A. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000; 32: 689-92.
Bacon BR. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
George DK, et al. Increased hepatic iron concentration in non- alcoholic steatohepatitis is associated with increased fibrosis. Gas- troenterology 1998; 114: 311-18.
Pinto HC, et al. Non-alcoholic steatohepatitis clinicopatho- logical comparison with alcoholic hepatitis in ambulatory and hospi- talized patients.
McCullough AJ, et al. Body composition and hepatic steatosis as precursors for fibrotic liver disease. Hepatology 1999; 29: 1328-30.
Day CP. Steatohepatitis: a tale of two hits? Gastroenterology 1998; 114: 842-5.
Pessayre D, et al. Mitochondrial steatohepatitis. Semin Liv Dis 2001; 21: 57-69.
Banjeri MA, et al. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin resistant black men with NIDDM. Int J Obes Relat Metab Disord 1995; 19: 846-50.
Marchesini G, et al. NASH: From liver disease to metabolic disorders and back to clinical Hepatology. Hepatology 2002; 35: 497-9.
Danie S, et al. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic patients. Am J Gastroenterol 1999; 94: 3010-4.
Falck-Ytter, et al. Clinical features and natural history of non alcoholic steatosis syndrome. Semin Liv Dis 2001; 21: 17-26.